TGFB1 and hepatoblastoma: As shown in Figure 3, TGF-β1 significantly (p < 0.01) promoted cell migration, which was inhibited when cotreated with ATD (25 μM and 50 μM) for 48 h in HepG2 hepatoblastoma cells significantly.